Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P53634: Variant p.Gly300Asp

Dipeptidyl peptidase 1
Gene: CTSC
Feedback?
Variant information Variant position: help 300 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glycine (G) to Aspartate (D) at position 300 (G300D, p.Gly300Asp). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to medium size and acidic (D) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In PLS. Any additional useful information about the variant.


Sequence information Variant position: help 300 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 463 The length of the canonical sequence.
Location on the sequence: help TPILSPQEVVSCSQYAQGCE G GFPYLIAGKYAQDFGLVEEA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         TPILSPQEVVSCSQYAQGCEGGFPYLIAGKYAQDFGLVEEA

Mouse                         TPILSPQEVVSCSPYAQGCDGGFPYLIAGKYAQDFGVVEES

Rat                           TPILSPQEVVSCSPYAQGCDGGFPYLIAGKYAQDFGVVEEN

Bovine                        TPILSPQEVVSCSQYAQGCEGGFPYLIAGKYAQDFGLVEED
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 231 – 394 Dipeptidyl peptidase 1 heavy chain
Binding site 302 – 302
Binding site 304 – 304
Disulfide bond 291 – 331
Alternative sequence 138 – 463 Missing. In isoform 2.
Alternative sequence 142 – 463 Missing. In isoform 3.



Literature citations
Evidence of a founder effect for four cathepsin C gene mutations in Papillon-Lefevre syndrome patients.
Zhang Y.; Lundgren T.; Renvert S.; Tatakis D.N.; Firatli E.; Uygur C.; Hart P.S.; Gorry M.C.; Marks J.J.; Hart T.C.;
J. Med. Genet. 38:96-101(2001)
Cited for: VARIANTS PLS PRO-272 AND ASP-300; Proxy molecular diagnosis from whole-exome sequencing reveals Papillon-Lefevre syndrome caused by a missense mutation in CTSC.
Erzurumluoglu A.M.; Alsaadi M.M.; Rodriguez S.; Alotaibi T.S.; Guthrie P.A.; Lewis S.; Ginwalla A.; Gaunt T.R.; Alharbi K.K.; Alsaif F.M.; Alsaadi B.M.; Day I.N.;
PLoS ONE 10:E0121351-E0121351(2015)
Cited for: VARIANT PLS ASP-300;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.